Table 1.
Clinical and laboratory characteristics
| Parameters | Total(N = 673) |
|---|---|
| Age (years) | 59.1 ± 10.8 |
| Male sex [n (%)] | 543(80.7) |
| Smoking [n (%)] | 315(46.8) |
| Alcohol intake[n (%)] | 251(37.3) |
| Hypertension [n (%)] | 323(48.0) |
| Family history of CAD [n (%)] | 145(21.5) |
| Hypercholesterolemia [n (%)] | 287(42.6) |
| Diabetes [n (%)] | 170(25.3) |
| LVEF (%) | 61 ± 7 |
| Regular drug taking[n (%)] | 594(88.3) |
| Pre-procedural laboratory parameters | |
| SBP (mmHg) | 134 ± 26 |
| HR (bpm) | 75 ± 10 |
| WBC (× 109/L) | 7.49 ± 2.33 |
| Monocyte (× 109/L) | 0.52 ± 0.22 |
| TG(mmol/l) | 1.61(1.18–2.48) |
| TC(mmol/l) | 4.04 ± 1.21 |
| LDL-C(mmol/l) | 1.32(1.06–2.22) |
| HDL-C(mmol/l) | 1.48(0.93–2.48) |
| Gensini score | 36(20–64) |
| MHR | 0.40 ± 0.30 |
| MHR quartiles | |
| Q1(≤0.19) | 167(24.8) |
| Q2(0.19–0.33) | 177(26.3) |
| Q3(0.33–0.53) | 158(23.5) |
| Q4(> 0.53) | 171(25.4) |
| Follow-up time (months) | 39 ± 25 |
WBC White blood cell, SBP Systolic blood pressure, HR Heart ratio, TG Triglyceride, TC Cholesterol, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, LVEF Left ventricular ejection fraction; Regular drug taking: angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker and statin were administered by medical advice, MHR Monocyte/HDL-C ratio